Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Oxygen free radical scavengers protect rat islet cells from damage by cytokines

  • 122 Accesses

  • 87 Citations

Summary

A possible role for oxygen free radicals in mediating the cytotoxic effects of cytokines in islets was sought by the use of agents that scavenge free radicals. Rat islet cell monolayer cultures were incubated for 6 days with t-butylhy-droperoxide, alloxan, streptozotocin, or the cytokines, interleukin 1, tumour necrosis factor, and interferon gamma, without and together with the oxygen free radical scavenger combination of dimethylthiourea and citiolone, and islet cell lysis was measured in a 15chromium cytotoxicity assay. The free radical scavengers significantly inhibited the islet cell cytotoxic effects of t-butylhydroperoxide and alloxan, but not streptozotocin. Similarly, the cytotoxic effects of the cytokine combinations of interleukin 1 plus tumour necrosis factor, interferon gamma plus tumour necrosis factor, and interferon gamma plus interleukin 1 were significantly inhibited by the free radical scavenger combination of dimethylthiourea and citiolone. These results suggest that the cytokine products of macrophages and lymphocytes infiltrating islets in Type 1 (insulin-dependent) diabetes may contribute to B-cell damage by inducing the production of oxygen free radicals in the islet cells.

References

  1. 1.

    Barbosa J, Bach FH (1987) Cell-mediated autoimmunity in Type I diabetes. Diabetes Metab Rev 3: 981–1004

  2. 2.

    Boitard C, Chatenoud LM, Debray-Sachs M (1982) In vitro inhibition of pancreatic β cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon. J Immunol 129: 2529–2531

  3. 3.

    Charlton BA, Bacelj A, Mandel TE (1988) Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide. Diabetes 37: 930–935

  4. 4.

    Wang Y, Hao L, Gill R, Lafferty KJ (1987) Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes 36: 535–538

  5. 5.

    Like AA, Biron CA, Weringer EJ, Byman K, Sroczynski E, Guberski DL (1986) Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 164: 1145–1159

  6. 6.

    Oschilewski U, Kiesel U, Kolb H (1985) Administration of silica prevents diabetes in BB rats. Diabetes 34: 197–199

  7. 7.

    Jacobson JD, Markmann JF, Brayman KL, Barker CF, Naji A (1988) Prevention of recurrent autoimmune diabetes in BB rats by anti asialo GM1 antibody. Diabetes 37: 838–841

  8. 8.

    Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH (1986) Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29: 63–67

  9. 9.

    Zawalich WS, Diaz VA (1986) Interleukin 1 inhibits insulin secretion from isolated perifused rat islets. Diabetes 35: 1119–1123

  10. 10.

    Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel M (1987) Interleukin 1 is potent modulator of insulin secretion from isolated islets of Langerhans. Diabetes 36: 963–970

  11. 11.

    Sandler S, Andersson A, Hellerström C (1987) Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 121: 1424–1431

  12. 12.

    Eizirik DL, Strandell E, Bendtzen K, Sandlers S (1988) Functional characteristics of rat pancreatic islets maintained in culture following exposure to human interleukin 1. Diabetes 37: 916–919

  13. 13.

    Eizirik D (1988) Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol (Copenh) 119: 321–325

  14. 14.

    Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J (1987) Human tumor necrosis factor potentiates human interleukin 1 mediated rat pancreatic β-cell cytotoxicity. J Immunol 139: 4077–4082

  15. 15.

    Pukel C, Baquerizo H, Rabinovitch A (1988) Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37: 133–136

  16. 16.

    Campbell IL, Iscaro A, Harrison LC (1988) IFN-γ and tumour necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J Immunol 141: 2325–2329

  17. 17.

    Ruddle NH (1987) Tumor necrosis factor and related cytotoxins. Immunol Today 8: 129–130

  18. 18.

    Mandrup-Poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jorgen-sen DW, Bendtzen K, Nielsen JH, Nerup J (1987) Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics. Diabetes 36: 641–647

  19. 19.

    Asayama K, Kooy NW, Burr IM (1986) Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J Lab Clin Med 107: 459–464

  20. 20.

    Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG (1982) Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc Natl Acad Sci USA 79: 927–930

  21. 21.

    Aloj Totaro E, Pisanti FA, Liberatori E (1985) Possible interrelation of acetyl-homocyteine-thiolactone in mechanisms of lipofuscinogenesis. Res Commun Chem Pathol Pharmacol 47: 415–426

  22. 22.

    Papaccio G, Pisanti FA, Frascatore S (1986) Acetyl-homocysteine-thiolactone-induced increase of Superoxide dismutase counteracts the effect of subdiabetogenic doses of streptozocin. Diabetes 35: 470–474

  23. 23.

    Fischer LJ, Rickert DE (1975) Pancreatic islet-cell toxicity. CRC Crit Rev Toxicol 3: 231–263

  24. 24.

    Wilson GL, Hartig PC, Patton NJ, LeDoux SP (1988) Mechanisms of nitrosourea-induced β-cell damage. Activation of poly (ADP-ribose) synthetase and cellular distribution. Diabetes 37: 213–216

  25. 25.

    LeDoux SP, Hall CR, Forbes PM, Patton NJ, Wilson G (1988) Mechanisms of nicotinamide and thymidine protection from alloxan and streptozotocin toxicity. Diabetes 37: 1015–1019

  26. 26.

    Autor AP (1984) Oxygen toxicity in eukaryotes. In: Bannister JV, Bannister WH (eds) The biology and chemistry of active oxygen: developments in biochemistry, Vol 26. Elsevier, Amsterdam, pp 139–145

  27. 27.

    Nathan CF, Tsunawaki S (1986) Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase. Ciba Found Symp 118: 211–230

  28. 28.

    Berton G, Zeni L, Cassatella MA, Rossi F (1986) Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 138: 1276–1282

  29. 29.

    Mendola J, Wright JR, Lacy PE (1989) Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozotocin-induced insulitis. Diabetes 38: 379–385

  30. 30.

    Nomikos IN, Prowse SJ, Carotenuto P, Lafferty KJ (1986) Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes 35: 1302–1304

  31. 31.

    Nomikos IN, Wang Y, Lafferty KJ (1989) Involvement of O2 radicals in autoimmune diabetes. Immunol Cell Biol 67: 85–87

  32. 32.

    Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H (1989) Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets by prediabetic BB rats. Diabetologia 32: 126–134

  33. 33.

    Appels B, Burkart V, Kantwerk-Funke G, Funda J, Kolb-Bachofen V, Kolb H (1989) Spontaneous cytotoxicity of macrophages against pancreatic islet cells. J Immunol 142: 3803–3808

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sumoski, W., Baquerizo, H. & Rabinovitch, A. Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 32, 792–796 (1989). https://doi.org/10.1007/BF00264909

Download citation

Key words

  • Islet cells
  • cytotoxicity
  • oxygen free radicals
  • interleukin 1
  • tumour necrosis factor
  • interferon gamma
  • alloxan
  • streptozotocin